Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline Effects on Neuroplasticity and Working Memory in Schizophrenia
NCT01934023Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Sep 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in schizophrenia, sponsored by Center for Addiction and Mental Health. Started Sep 2013; status: completed.
02
Drugs
varenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01934023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01934023.